In another study administration of p53 mRNA using redox-responsive nanoparticles led to a substantial reduction in the viability of p53-null lung cancer cells and a marked decrease in tumor size in mouse models of hepatocellular carcinoma (HCC) and NSCLC [657]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.